These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 23311095)

  • 1. PHARMAC's effectiveness threatened by TPPA restrictions.
    Nurs N Z; 2012 Oct; 18(9):7. PubMed ID: 23311095
    [No Abstract]   [Full Text] [Related]  

  • 2. TPPA is good for NZ--yeah, right!
    Symes H
    Nurs N Z; 2012 Aug; 18(7):4. PubMed ID: 23029790
    [No Abstract]   [Full Text] [Related]  

  • 3. The kaiwhakahaere comments.
    Nuku K
    Nurs N Z; 2016 May; 22(4):5. PubMed ID: 27396041
    [No Abstract]   [Full Text] [Related]  

  • 4. The role of the pharmaceutical industry in disseminating pharmacovigilance practice in developing countries.
    Shani S; Yahalom Z
    Food Drug Law J; 2008; 63(3):701-11. PubMed ID: 19031669
    [No Abstract]   [Full Text] [Related]  

  • 5. Trade treaties centre on science.
    Cressey D
    Nature; 2015 May; 521(7553):401-2. PubMed ID: 26017420
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharma's next frontier? New threats to public health in the Regional Comprehensive Economic Partnership agreement.
    Townsend B; Gleeson D; Lopert R
    Aust N Z J Public Health; 2016 Feb; 40(1):5-6. PubMed ID: 26456476
    [No Abstract]   [Full Text] [Related]  

  • 7. Global harmonization is not all that global: divergent approaches in drug safety.
    Castle GH; Kelly B
    Food Drug Law J; 2008; 63(3):601-22. PubMed ID: 19031662
    [No Abstract]   [Full Text] [Related]  

  • 8. Regarding 'Is PHARMAC's sole-supply tendering policy harming the health of New Zealanders?' editorial.
    Gray B
    N Z Med J; 2005 May; 118(1215):U1481; discussion U1481. PubMed ID: 15915196
    [No Abstract]   [Full Text] [Related]  

  • 9. Merck responds to PHARMAC's article on COX-2 inhibitors.
    Woolner D
    N Z Med J; 2005 Nov; 118(1225):U1746. PubMed ID: 16286953
    [No Abstract]   [Full Text] [Related]  

  • 10. Trans-Pacific Partnership Agreement and the public health.
    Beard M
    N Z Med J; 2015 May; 128(1415):41-3. PubMed ID: 26117511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Australia amends its free trade deal with US to lessen effect on drug costs.
    Burton B
    BMJ; 2004 Aug; 329(7463):420. PubMed ID: 15321891
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug regulation 2056.
    Bezold C; Peck J
    Food Drug Law J; 2005; 60(2):127-36. PubMed ID: 16097091
    [No Abstract]   [Full Text] [Related]  

  • 13. . . . and Brazilian AIDS programme threatened by US trade action.
    Int J Epidemiol; 2001 Apr; 30(2):413. PubMed ID: 11369751
    [No Abstract]   [Full Text] [Related]  

  • 14. Is PHARMAC's decision making fair? Findings from an evaluation of decision-making in the New Zealand health system.
    Tumilty E; Doolan-Noble F; Gauld R; Littlejohns P; Stokes T
    N Z Med J; 2022 Feb; 135(1550):170-177. PubMed ID: 35728164
    [No Abstract]   [Full Text] [Related]  

  • 15. The influence of PHARMAC's National Hospital Pharmaceutical Strategy on Quality Use of Medicines activities in New Zealand hospitals.
    Tordoff J; Norris P; Kennedy J; Reith D
    N Z Med J; 2006 Aug; 119(1239):U2100. PubMed ID: 16912718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nurses must fight TPPA threat.
    O'Connor T
    Nurs N Z; 2012 Jun; 18(5):13. PubMed ID: 22880358
    [No Abstract]   [Full Text] [Related]  

  • 17. The Transatlantic Trade and Investment Partnership and UK healthcare.
    Hilary J
    BMJ; 2014 Nov; 349():g6552. PubMed ID: 25378246
    [No Abstract]   [Full Text] [Related]  

  • 18. PHARMAC's updated guidelines for cost-effectiveness analyses, with new discount rate.
    Grocott R; Metcalfe S
    N Z Med J; 2007 Jul; 120(1258):U2641. PubMed ID: 17653257
    [No Abstract]   [Full Text] [Related]  

  • 19. Thousands protest TPPA signing.
    Nurs N Z; 2016 Feb; 22(1):10. PubMed ID: 27039568
    [No Abstract]   [Full Text] [Related]  

  • 20. Patentable subject matter, TRIPS and the European Biotechnology Directive: Australia and patenting human genes.
    Palombi L
    Univ N S W Law J; 2003; 26(3):782-92. PubMed ID: 16617532
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.